Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Posterior pole tumor update.

Judy I Ou1, Sharon M Wheeler, Joan M O'Brien

  • 1Ocular Oncology Unit, Department of Ophthalmology, University of California at San Francisco, Room K-301, Box 0730, 10 Koret Way, San Francisco, CA 94143-0730, USA.

Ophthalmology Clinics of North America
|January 8, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating therapeutic response to netarsudil in glaucoma subjects with the <i>ARHGEF12</i> risk variant.

Frontiers in pharmacology·2026
Same author

Variant-to-gene mapping identifies <i>ARHGEF12</i> as a primary open-angle glaucoma effector gene operating within retinal ganglion cells.

bioRxiv : the preprint server for biology·2026
Same author

Mapping rare protein-coding variants on multi-organ imaging traits.

Nature communications·2025
Same author

3D chromatin-based variant-to-gene maps across 57 human cell types reveal the cellular and genetic architecture of autoimmune disease susceptibility.

Genome biology·2025
Same author

Multimodal Prediction of Primary Open-Angle Glaucoma Using Polygenic Risk Scores and Clinical Features in a High-Risk African Ancestry Cohort.

medRxiv : the preprint server for health sciences·2025
Same author

Risk factors associated with beta-peripapillary atrophy in individuals of African ancestry with primary open-angle glaucoma.

Eye (London, England)·2025
Same journal

Contrast sensitivity and measuring cataract outcomes.

Ophthalmology clinics of North America·2006
Same journal

Capsular tension rings: update on endocapsular support devices.

Ophthalmology clinics of North America·2006
Same journal

Management of vitreous loss and dropped nucleus during cataract surgery.

Ophthalmology clinics of North America·2006
Same journal

Astigmatism control.

Ophthalmology clinics of North America·2006
Same journal

New technology IOL optics.

Ophthalmology clinics of North America·2006
Same journal

Phaco fluidics and phaco ultrasound power modulations.

Ophthalmology clinics of North America·2006
See all related articles

This chapter reviews recent findings on choroidal melanoma and retinoblastoma management, highlighting shifts toward less invasive treatments and genetic testing for various posterior pole tumors.

Area of Science:

  • Ophthalmology
  • Oncology

Background:

  • Choroidal melanoma and retinoblastoma are significant intraocular tumors.
  • Other posterior pole tumors include vascular, glial, and retinal pigment epithelium tumors, some linked to systemic disease.

Purpose of the Study:

  • To provide an overview of posterior pole tumors.
  • To highlight recent advances in diagnosis and management.
  • To discuss the association of certain tumors with systemic diseases.

Main Methods:

  • Review of recent findings from the Collaborative Ocular Melanoma Study (COMS).
  • Discussion of current treatment trends, including chemoreduction and local therapy for retinoblastoma.
  • Integration of information on ocular metastasis, lymphoid tumors, and leukemia.

Related Experiment Videos

Main Results:

  • Treatment for retinoblastoma is shifting from external beam radiation therapy (EBRT) to chemoreduction with local therapy.
  • Genetic testing advances aid in managing these ocular diseases.
  • Understanding tumor associations with systemic conditions is crucial for prognosis.

Conclusions:

  • Recent developments offer improved diagnostic and management strategies for intraocular tumors.
  • Personalized treatment approaches are increasingly important.
  • Early detection and understanding systemic links improve patient outcomes.